Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Dalton Transactions (Cambridge, England : 2003)|May 14, 2015
Mechanistic insights into a novel chromone-appended Cu(II) anticancer drug entity: in vitro binding profile with DNA/RNA substrates and cytotoxic activity against MCF-7 and HepG2 cancer cellsImtiyaz Yousuf, Farukh Arjmand, Sartaj Tabassum, et al.
European Journal of Medicinal Chemistry|June 24, 2014
Synthesis and crystal structure determination of copper(II)-complex: In vitro DNA and HSA binding, pBR322 plasmid cleavage, cell imaging and cytotoxic studiesSartaj Tabassum, Mehvash Zaki, Musheer Ahmad, et al.
Carbohydrate Research|November 8, 2011
Carbohydrate-conjugate heterobimetallic complexes: synthesis, DNA binding studies, artificial nuclease activity and in vitro cytotoxicitySartaj Tabassum, Rais Ahmad Khan, Farukh Arjmand, et al.
Dalton Transactions (Cambridge, England : 2003)|October 1, 2013
Chiral heterobimetallic complexes targeting human DNA-topoisomerase IαSartaj Tabassum, Ahmad Asim, Rais Ahmad Khan, et al.
Bioorganic Chemistry|May 10, 2019
Evaluation of cytotoxic activity and genotoxicity of structurally well characterized potent cobalt(II) phen-based antitumor drug entities: An in vitro and in vivo approachHuzaifa Yasir Khan, Mohd Owais Ansari, G G H A Shadab, et al.
Journal of Biomolecular Structure & Dynamics|December 17, 2020
Biophysical binding profile with ct-DNA and cytotoxic studies of a modulated nanoconjugate of umbelliferone cobalt oxide loaded on graphene oxide (GO) as drug carrierShariq Yousuf, Farukh Arjmand, Hifzur R Siddique, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|February 9, 2023
A novel Cu(II)-based DNA-intercalating agent: Structural and biological insights using biophysical and in silico techniquesElaheh Movahedi, Hafez Razmazma, Alireza Rezvani, et al.
Biophysical Chemistry|July 21, 2025
Inhibition of nucleation and disruption of amyloid fibrillation in human lysozyme aggregation by a potent Cu(II) flufenamate chemotherapeutic drug candidateHuzaifa Yasir Khan, Yassir Hasan Khan, Md Nadir Hassan, et al.
European Journal of Medicinal Chemistry|January 8, 2013
Mixed-ligand Cu(II)-vanillin Schiff base complexes; effect of coligands on their DNA binding, DNA cleavage, SOD mimetic and anticancer activitySartaj Tabassum, Samira Amir, Farukh Arjmand, et al.
Biophysical Chemistry|March 1, 2024
Biophysical insight into anti-amyloidogenic nature of novel ionic Co(II)(phen)(H2O)4]+[glycinate]- chemotherapeutic drug candidate against human lysozyme aggregationAiman Masroor, Nida Zaidi, Faisal Nabi, et al.
Pageof 10